Genome-wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-treatment With 5-Azacytidine and Entinostat
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2016
Price : $35 *
At a glance
- Drugs Azacitidine (Primary) ; Entinostat (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacodynamics; Pharmacogenomic
- 17 May 2015 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 03 Mar 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 11 Feb 2015 Planned primary completion date changed from 1 Apr 2016 to 1 Feb 2015, as reported by ClinicalTrials.gov.